The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with …

MB Amin, DW Lin, JL Gore… - … of Pathology and …, 2014 - meridian.allenpress.com
Context.—Prostate cancer remains a significant public health problem. Recent publications
of randomized trials and the US Preventive Services Task Force recommendations have …

Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature

FKH Chun, JI Epstein, V Ficarra, SJ Freedland… - European urology, 2010 - Elsevier
CONTEXT: The number and location of biopsy cores and the interpretation of prostate
biopsy in different clinical settings remain the subjects of continuing debate. OBJECTIVE …

Molecular map** of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots

J Liu, SK Lau, VA Varma, RA Moffitt, M Caldwell, T Liu… - ACS …, 2010 - ACS Publications
Tumor heterogeneity is one of the most important and challenging problems not only in
studying the mechanisms of cancer development but also in develo** therapeutics to …

Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis

R Damiano, G Di Lorenzo, F Cantiello, M De Sio… - European urology, 2007 - Elsevier
OBJECTIVES: To review all relevant features of incidentally discovered prostate cancer
(PCa) in patients undergoing radical cystectomy for bladder cancer: incidence, pathologic …

Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent …

M Jung, MS **, C Kim, C Lee, IP Nikas, JH Park… - Modern …, 2022 - nature.com
Accurate diagnosis and grading of needle biopsies are crucial for prostate cancer
management. A uropathologist-level artificial intelligence (AI) system could help make …

Initial extended transrectal prostate biopsy—are more prostate cancers detected with 18 cores than with 12 cores?

V Scattoni, M Roscigno, M Raber, F Dehò… - The Journal of …, 2008 - auajournals.org
Purpose: We retrospectively investigated the detection rates of prostate cancer, high grade
prostatic intraepithelial neoplasia and atypical glands suggestive of carcinoma by initial 18 …

Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review

A Leone, B Gershman, K Rotker, C Butler… - Prostate Cancer and …, 2016 - nature.com
Background: Atypical small acinar proliferation (ASAP) occurs in approximately 5% of
prostate biopsies. Approximately 30–40% of patients with ASAP may develop prostate …

Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?

RP Dorin, S Wiener, CD Harris, JR Wagner - The Prostate, 2015 - Wiley Online Library
Background While the treatment pathway in response to benign or malignant prostate
biopsies is well established, there is uncertainty regarding the risk of subsequently …

Reassessing the diagnostic yield of saturation biopsy of the prostate

RA Ashley, BA Inman, JC Routh, LA Mynderse… - European urology, 2008 - Elsevier
OBJECTIVE: Prostate biopsy remains the gold standard for detection of prostate cancer
(PCa). This study was performed to determine whether saturation biopsy (≥ 24 cores) …

Transrectal prostate biopsy

MT Ismail, LG Gomella - Urologic Clinics, 2013 - urologic.theclinics.com
Prostate cancer (PCa) is the most common neoplasm in the Western hemisphere, and the
incidence is still increasing. 1 Screening, detection, and diagnosis of PCa are currently …